- Report
- August 2025
- 145 Pages
Global
From €5248EUR$5,950USD£4,611GBP
- Report
- August 2025
- 145 Pages
Global
From €5248EUR$5,950USD£4,611GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- February 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 185 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- January 2025
- 157 Pages
Global
From €4406EUR$4,995USD£3,871GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,602GBP
€3484EUR$3,950USD£3,061GBP
- Report
- October 2025
- 87 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- August 2025
- 120 Pages
United States
From €5248EUR$5,950USD£4,611GBP
- Report
- August 2025
- 120 Pages
United States
From €5248EUR$5,950USD£4,611GBP
- Report
- September 2025
- 85 Pages
United States
From €3087EUR$3,500USD£2,712GBP
- Report
- August 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- December 2025
- 273 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 225 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- October 2025
- 87 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- October 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- December 2025
- 479 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- August 2024
- 66 Pages
Global
From €1103EUR$1,250USD£969GBP

The Small Molecule CMO market is a subset of the Pharmaceutical Manufacturing industry, focusing on the production of small molecule drugs. Small molecule drugs are typically composed of organic molecules, and are used to treat a variety of conditions, from cancer to cardiovascular disease. CMOs provide a range of services, from drug development and clinical trials to manufacturing and packaging. They are often used to reduce the cost and time associated with drug development, as well as to increase the efficiency of the manufacturing process.
CMOs are typically divided into two categories: contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). CMOs focus on the production of small molecule drugs, while CDMOs provide a range of services, from drug development to manufacturing and packaging.
Companies in the Small Molecule CMO market include Boehringer Ingelheim, Catalent, Lonza, Patheon, and Recipharm. Show Less Read more